We and others have previously identified microRNAs (miRNAs) with pathological roles in animal models of asthma, where miR-146a and miR-155 have been described to play important roles in inflammatory responses. To date, few studies have investigated miRNA expression in human asthmatics. In the current study, significantly lower levels of miR-155 were detected in cell-free sputum from allergic asthmatics compared to healthy controls. Induced sputum isolated from allergic asthmatics in and out of pollen season revealed that miR-155 expression, but not miR-146a, is reduced in lymphocytes in season compared to post-season. In contrast, miR-155 was found to increase, whereas miR-146a decreased in PBMCs and cell-free PBMC culture media upon T cell receptor stimulation via aCD3/CD28 in both allergic asthmatics and healthy controls. Our findings suggest that miR-155 is differentially expressed ex vivo in airways of allergic asthmatics compared to healthy controls, which may have implications in the local immune response in allergic asthma.
Introduction
Allergic asthma is a common chronic inflammatory disease characterized by type 2-mediated inflammation which leads to blood and airway eosinophilia [1] . MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at post-transcriptional level in a tissue-and cellspecific manner. A limited number of studies have investigated miRNA expression in human asthmatics [2] [3] [4] [5] [6] , and miRNA expression in specific cellular subtypes in asthmatics is largely unexplored [7] [8] [9] [10] [11] . Therefore, the aim of this study was to assess miR-146a and miR-155 expression in airways-and blood-derived samples from allergic asthmatics and healthy controls. The two miRNA candidates have previously been described to play important roles in inflammatory responses in both humans and mice. miR-155 has in later years emerged as a new important modulator in experimental investigations of asthma and allergy where we have demonstrated that miR-155 is essential in allergen-induced eosinophilic inflammation locally in the airways in a murine model of allergic airway inflammation [12, 13] . Furthermore, there are reports indicating an involvement of miR-155 in human asthma and allergy from ex vivo examinations of human airway specimens from asthmatics and healthy controls [2, 4, 8] . miR-146a has also been linked to asthma and allergy [8, [14] [15] [16] [17] [18] [19] , however, in contrast to miR-155, miR-146a has been described to have an anti-inflammatory role [16, 17] . Our study demonstrates that alternating expression levels of miR-146a and miR-155 upon in vitro stimulation of peripheral blood mononuclear cells (PBMCs) fail to distinguish allergic asthmatics from healthy controls. However importantly, a significant dysregulation of miR-155 was found in airways of allergic asthmatic individuals compared to healthy controls. Our finding that miR-155 is decreased in sputum lymphocytes from allergic asthmatics in pollen season compared to allergic asthmatics postseason, indicates that miR-155 is playing a role in the immune response locally in the airways in vivo in human asthmatics.
Material and methods
Subjects. Allergic asthmatics (n = 16) and healthy controls (n = 13) were recruited from the West Sweden Asthma Study [20, 21] . In brief, asthmatics were defined as individuals with physician diagnosed asthma or diagnosed from reports of common asthma symptoms and responsiveness to methacholine. Atopy was defined as the presence of at least one positive skin prick test using a standard panel of 11 aeroallergens which comprise birch, mugwort, timothy, horse, dog, cat, cockroach, Cladosporium, Alternaria, Dermatophagoides farinae and D. pteronyssinus (ALK, Hørsholm, Denmark). Allergic asthmatics recruited in and out of pollen season had at least one positive skin prick test towards birch and/or timothy. Serum samples were analysed for IgE using Phadiatop â test for inhalant allergens (ImmunoCAP, Thermo Fisher Scientific, Uppsala, Sweden) [22] . Healthy control subjects were non-asthmatic individuals, demonstrated negative skin prick test and IgE levels <0.35 kU A . All participants were non-smokers and above 18 years of age. Written informed consent was received from all subjects. The study was approved by the Ethics Committee at the University of Gothenburg (Dnr. 593-08). Demographic and clinical characteristics of study participants can be found in Table 1 . Sputum induction and processing. Sputum samples were induced and processed according to the ERS guidelines [23, 24] with minor modifications. In brief, subjects inhaled 400 lg salbutamol prior to sputum induction using a pressurized metered-dose inhaler. Sputum was performed by inhalation of hypertonic saline (NaCl 4%) using an ultrasonic nebulizer. The aerosol was inhaled for two consecutive periods of 7 min. Pre-and post-bronchodilator FEV 1 measurements were performed to ensure participant safety, and collection was stopped whenever symptoms of obstruction occurred. The sputum specimens were processed immediately, using a modified method [25] . Sputum plugs were selected, weighed and then mixed with Sputolysin (6.5 mM dithiothreitol in 100 mM phosphate buffer, pH 7.0; Calbiochem-Novabiochem, Darmstadt, Germany) and incubated at RT for 15 min on a bench mixer. Dulbecco's phosphate-buffered saline (D-PBS, Sigma-Aldrich) was added to an equal volume to the homogenized sputum and then passed through a 70-lm cell strainer. Finally, the sample was centrifuged, supernatant was collected and immediately frozen at À80°C until analysis. The cell pellet was resuspended in 1 ml 0.03% BSA/PBS solution. Viability was evaluated using Trypan Blue exclusion. Cytospins were prepared from the cell pellet, stained with May-Gr€ unwald-Giemsa stain and differential cell counts were established by counting 300 cells. For samples obtained for cell sorting, whole sputum was processed and no supernatant was collected. Cells were stained with mouse anti-human CD45-PerCP antibody (Clone 2D1, BD Biosciences, San Jose, CA, USA). Monocytes and lymphocytes were gated based on side scatter and CD45 expression (Fig. 4B) , Grand Island, NY, USA) alone or in plates precoated with anti-CD3/anti-CD28 (hereafter referred to as aCD3/CD28; 1 lg each/ml; BD Pharmingen TM , BD Biosciences) for 48 h. Cell-free supernatant were collected and stored at À80°C until analysis. The cell pellet was washed once with PBS and resuspended in RLT buffer (Qiagen), and stored in À80°C until analysis.
miRNA detection. Total RNA from cell-free sputum supernatant (140 ll), cell-free PBMC-derived in vitro supernatants (140 ll) and FACS-sorted cells were isolated using miRNeasy micro Kit (Qiagen, Hilden, Germany), and contaminating DNA was removed with the Turbo DNA-free TM kit (Ambion, Life technologies, Carlsbad, CA, USA) according to manufacturer's protocol. Total RNA was purified from PBMCs using a combination of RNeasy Mini Kit (Qiagen) and RNeasy MinElute Cleanup kit (Qiagen) to separate small and large RNA. The larger fraction (>200 nucleotides) was bound to the RNeasy Mini spin column, and the flow-through containing small RNA was processed further as a separate sample on RNeasy MinElute spin columns. Following RNA elution and DNase treatment, RNA yield and integrity was evaluated using chip-based (Agilent RNA 6000 Pico RNA Kit) capillary electrophoresis (Agilent 2100 Bioanalyzer, Agilent Technologies, Waldbronn, Germany) running 2100 Expert Software (Agilent Technologies) following the manufacturer's instruction. Reverse transcription of miRNA was performed in replicates using Universal cDNA synthesis kit (Exiqon A/S, Vedbaek, Denmark). Quantitative real-time PCR in triplicates was performed on a CFX-96 Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) by using diluted cDNA. LNA primer sets for hsa-miR-155-5p, hsa-miR-146a-5p and hsa-miR-103a-3p, and the ExiLent SYBR â green
Master Mix kit were used as described by the manufacturer (Exiqon). To determine expression, miR-155 and miR146a were normalized to miR-103a in each sample using CFX Manager 3.0 Software (Bio-Rad). UniSp6 RNA Statistical analysis. Statistical analysis using MannWhitney U-test between two independent groups or paired t-test between paired samples was used to determine statistical significance using IBM SPSS Statistics 22.0 (IBM Corp. Armonk, NY, USA) or GRAPH PAD PRISM 6 Software (GraphPad Software Inc, La Jolla, CA, USA). P-values <.05 were considered statistically significant. Values in Table 2 and histograms are expressed as mean AE SEM. Table 1 is presented as median with range, and scatter plots are expressed as mean.
Results

Increased eosinophils in blood and airways of allergic asthmatics
This study included mild-to-moderate asthmatics as shown by comparable median values of % predicted FEV 1 between allergic asthmatics and healthy control subjects ( Table 1) . As expected, significantly higher levels of sIgE were found in the allergic asthmatic group compared to the healthy control group used in this study (Table 1) . Eosinophil content in peripheral blood and induced sputum is commonly used to identify eosinophilic asthma. Accordantly, we found that blood eosinophil counts were significantly higher in allergic asthmatics (Table 1) , and the total number of cells (Fig. 1A) including eosinophils ( Fig. 1B ; representative sputum eosinophil shown in Fig. 1C) were significantly increased in induced sputum from allergic asthmatics as compared to healthy controls.
miR-146a and miR-155 are altered in cell-free sputum
We next assessed leucocyte content in sputum by flow cytometric analysis. A higher percentage of CD45 + cells were found in induced sputum from allergic asthmatics compared to healthy controls ( Fig. 2A) . Interestingly, cell-free sputum supernatants from the allergic asthmatic group demonstrated significantly lower levels of miR-155 compared to healthy controls (Fig. 2B) , suggesting that the diverse immune cell composition in sputum results in alternative miRNA expression levels. The level of miR-146a demonstrated a trend towards a lower level in allergic asthmatic than in healthy controls (Fig. 2B) .
miR-146a and miR-155 are altered in cell-free PBMC culture supernatants upon stimulation T cells are known to drive type 2 immune responses which orchestrate eosinophilic inflammation. Thus, we next cultured PBMCs in vitro from allergic asthmatics and healthy controls to investigate miRNA expression upon stimulation of the T cell receptor (TCR) via aCD3/CD28 for 48 h. Analysis of cell-free conditioned culture media revealed that miR-146a decreased upon stimulation, while miR-155 levels increased in the culture media as a result of T cell stimulation (Fig. 2C) . However importantly, the strong stimulation resulted in altered expression levels of miR-146a and miR-155 that were similar for the allergic asthmatic group and the healthy control group.
Pro-inflammatory cytokines in cell-free PBMC culture supernatants upon stimulation miR-146a and miR-155 have previously been described to be involved in anti-and pro-inflammatory processes, respectively [12, 13, 16, 17, [27] [28] [29] . Thus, we next analysed inflammatory cytokines (IL-2, IL-4, IL-5, IL-6, IL-10, IL-17A, IFNc and TNF) in the conditioned PBMC culture media. All of the eight cytokines analysed were elevated in conditioned media from stimulated cells compared to unstimulated control cells (Table 2) obtained from both allergic asthmatics and healthy controls. However, significantly higher levels of IL-4 were detected in the media from stimulated PBMCs of allergic asthmatics than in media from stimulated PBMCs of healthy controls, possibly highlighting the close relationship between IL-4 and atopy.
Eosinophils increase in sputum from allergic asthmatics in pollen season
To further investigate miRNA expression related to cell stimulation, we collected induced sputum from allergic asthmatics in pollen season (April to June) and postpollen season (October). Similar numbers of blood eosinophils were found in allergic asthmatics in and out of season (data not shown). However, a total number of sputum cells (Fig. 3A ) and sputum eosinophils (Fig. 3B) were significantly increased in samples obtained in pollen season as compared to post-season, clearly demonstrating that elevated pollen levels resulted in immune activation in the airways of the allergic asthmatic group.
Expression of miR-146a and miR-155 in PBMCs upon stimulation is reflected in cell-free supernatants miRNAs regulate gene transcription in the cytoplasm; however, miRNAs are also present in extracellular fluids where they act as signalling molecules between cells [30] . Whether extracellular expression profiles truly reflect intracellular expression is still a topic of investigation. In our analysis of intracellular levels of miR-146a and miR-155 in in vitro-stimulated PBMCs from allergic asthmatics, an identical expression pattern was found in cells and in cell-free culture supernatants. miR-146a was significantly decreased upon TCR stimulation compared to unstimulated control cells, while miR-155 expression increased in cells upon stimulation (Fig. 4A ). ............................................................................................................................................................... 
miR-155 is differentially expressed in sputum lymphocytes from allergic asthmatics during pollen season
Lymphocytes and monocytes are the most numerous cells in a PBMC sample. Thus, the altered levels of miR-146a and miR-155 upon TCR stimulation of PBMC cultures might be mediated by lymphocytes and possibly affect monocytes. To test this hypothesis in the afflicted site, we employed an ex vivo approach where we sorted monocytes and lymphocytes from sputum based on side scatter together with CD45 expression (representative FACS plot in Fig. 4B ; see sputum presorting and sorted cells in Fig. 4C ). The sorting strategy proved successful and generated cellular fractions that demonstrated high purity as confirmed by morphological examination of contraststained cells (Fig. 4C) . Induced sputum samples were collected in and out of pollen season. Interestingly, not previously shown, we found that miR-155 expression was significantly decreased in sputum lymphocytes obtained in season compared to lymphocytes post-pollen season (Fig. 4D) . This was found to be highly specific as the expression of miR-155 in monocytes (Fig. 4E ) and miR146a in lymphocytes (Fig. 4F) and monocytes (Fig. 4G ) was unchanged. This result indicates that miR-155 is taking part in the immune response locally in the airways in vivo in human asthmatics.
Discussion
Asthma is a common chronic inflammatory disease characterized by airway hyper-responsiveness to direct or indirect stimulation by allergens and irritants, where airway inflammation may persist even when symptoms are absent and lung function is normal [1] . Consistent with the 304 Altered miR-155 in Airways classic eosinophilic phenotype of allergic asthma, the allergic mild-to-moderate asthmatic group demonstrated significantly elevated eosinophil counts in induced sputum (Fig. 1A) and in peripheral blood (Table 1) . Furthermore, the total number of cells was found to be significantly higher in sputum from allergic asthmatics compared to sputum obtained from healthy individuals (Fig. 1B) . Closer examination by flow cytometry confirmed a marked increase of infiltrating leucocytes in sputum from allergic asthmatics ( Fig. 2A) which is expected in sites of inflammation. The altered cellular composition was accompanied by significantly lower expression levels of miR-155 in cellfree sputum from allergic asthmatics compared to healthy controls (Fig. 2B) . miRNAs have previously been reported to be differentially expressed in exhaled breath condensate which represents a sample of the fluid lining the respiratory tract [2] . In this study, expression levels of miR-155 were found to be significantly lower in asthmatics than in healthy subjects, a result that is in line with our analysis of miR-155 expression in cell-free sputum. Indeed, miR-155 is one of the most studied miRNAs in the literature and has been described to play important roles in host defence which includes lymphocyte responses to allergens [12, 13, 17] . We hypothesized that the observed downregulation of miR-155 in cell-free sputum might be an implication of lymphocyte dysfunction in airways of allergic asthmatics. However, due to limitations in cell yield in induced sputum, we continued our investigations in an in vitro setting where we utilized PBMCs of allergic asthmatics and healthy controls, as the most abundant cells in PBMC-isolates are lymphocytes and monocytes. These circulating immune cells are thought to be important in inflammatory conditions by being recruited to inflamed sites where they acquire distinct phenotypes depending on antigens and cytokines present [31] . TCR activation via aCD3/CD28 stimulation resulted in significantly decreased expression levels of miR-146a and significantly increased expression levels of miR-155 in PBMC cultures (Fig. 2C) . The extracellular expression pattern found in cell-free conditioned PBMC media was reproduced in the cellular fraction (Fig. 4A) . Consistent with our finding that miR-155 was upregulated upon TCR stimulation, a previous study in mice reported elevated levels of miR-155 at 48 h in splenic CD4 + T cells upon aCD3/CD28 stimulation in vitro [27] . Furthermore, the same study showed that miR-146a was downregulated at the given time point, thereby recapitulating the complimentary expression pattern of miR-146a and miR-155 displayed in the present study. Furthermore, a human study demonstrated that miR-155 was overexpressed in inflammatory cells in the skin of patients with atopic dermatitis [32] . The same study also showed that PBMCs isolated from patients with atopic dermatitis significantly increased miR-155 expression upon aCD3/CD28 stimulation in vitro compared to unstimulated cells; miR-155 in PBMCs from healthy donors demonstrated a strong trend towards increased expression levels upon stimulation, as seen in our study (Fig. 2C) . Interestingly, a study of miRNA profiles in human airways demonstrated that in nasal mucosa of patients with allergic and non-allergic rhinitis, miR-155 was shown to be significantly elevated in subjects with current allergic rhinitis and in patients with positive skin prick test reactions [33] . These data highlight a role of miR-155 in type 2-mediated allergic inflammation in human airways. However, a more recent study from the same group demonstrated lower levels of miR-155 in nasal mucosa of subjects with chronic allergic asthma compared to healthy controls [4] . This downregulation corresponded with lack of differences in nasal eosinophils or levels of type 2 cytokines (IL-5, IL-13, IL-4), thereby suggesting a predominant role for miR-155 in acute allergic inflammation. This result is at least in part in agreement with our findings which demonstrated a concomitant increase of type 2 cytokines and miR-155 expression following acute in vitro stimulation of PBMCs from both allergic asthmatics and healthy controls. At the same time, a downregulation of miR-155 was found ex vivo in sputum from chronic inflamed airways of allergic asthmatics compared to healthy airways (Fig. 2B) . Related to this, in our previous work we have shown that even though miR-155 expression increases in airways in mice upon induction of chronic allergic inflammation [13] , the expression levels detected in this setting are considerably lower than the induction of miR-155 expression that is generated in an acute allergic inflammation [12] . Importantly, in the present study, the increase of miR-155 and the decrease of miR-146a coincided with increased inflammatory cytokines in PBMC cultures as a result of cell stimulation. IL-4 was the only cytokine found to be significantly increased in the allergic asthmatic group compared to the healthy control group upon stimulation ( Table 2 ). Overproduction of IL-4 has long been associated with allergies [34] by inducing B cell class switching to IgE. Thus, increased IL-4 production in the allergic asthmatic group corresponds well with our measurements of elevated serum sIgE in these individuals (Table 1) . However, the in vitro system that was utilized to overcome limitations of cellular yield in sputum, proved to be unable to distinguish the allergic asthmatic group from healthy controls in terms of miRNA expression. One might speculate that the reason for this could be due to the fact that the aCD3/ CD28 stimulation was too strong and thereby caused an exaggerated response. To address this problem and at the same time test the hypothesis that altered expression of miR146a and miR-155 in PBMC cultures are mediated by lymphocytes and monocytes, we continued our investigation by analysing sputum cells ex vivo. Induced sputum was collected in and out of pollen season from individuals in the allergic asthmatic group that were allergic to pollen. These subjects were clearly affected by elevated levels of naturally occurring pollen as seen by a significant increase in total sputum cells (Fig. 3A) as well as sputum eosinophils (Fig. 3B ) in season as compared to post-season, and in addition, all subjects reported to be symptom free postseason. Interestingly, not previously shown, we found that miR-155 expression was significantly lower in sputum lymphocytes obtained from allergic asthmatics in season compared to sputum lymphocytes from the same allergic asthmatic subjects post-pollen season (Fig. 4D) . Similar levels of miR-155 were found in lymphocytes in induced sputum from healthy controls (data not shown) as in lymphocytes of allergic asthmatics post-season, suggesting that miR-155 is indeed playing a role in the inflammatory response during pollen season locally in the airways of allergic asthmatics.
In this study, we demonstrate, for the first time, differential expression of miR-155 in airway lymphocytes of allergic asthmatics. miR-155 is emerging as a key regulatory component in experimental settings of allergic asthma. To this end, the present study expands on the existing literature by incorporating sputum lymphocytes from human asthmatics among the potential cellular targets by which miR-155 regulates immune responses in vivo.
